Sandoz, Teva, Others Face AbbVie Drug Patent Battle – Law360

29th October 2022

Sandoz, Teva, Others Face AbbVie Drug Patent Battle Law360

OPUS IP on X (formerly Twitter)…

Twitter feed is not available at the moment.

RECENT PATENT NEWS…

Taiwan: The ordinary consumer and naked-eye observation test in design patent infringement - Managing Intellectual Property
Inventor prevails as Court of Appeal calls for compensation law reform - ICLG
Brazilian court grants InterDigital injunction against TCL over HEVC patents - StreetInsider
Former Samsung VP Gets 3-Year Prison Term Over Confidential Data Leak - SammyGuru

UK BUSINESS NEWS…

Mbappé dropped by major Chinese brands drop as backlash grows over Mao joke
Budget measures to include fuel duty freeze and food tariff cuts
Apple says it will replace iPhone Duo handsets with screen problems
I'm a single mum on £41,000 and limit my weekly shop to £40 - it's hard

Designed by Industrial Action

Copyright © 2026 OPUS IP Limited. All Rights Reserved

OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION